Home » Topics » BioWorld Science

BioWorld Science
RSS

Symphony receives grant related to HMG-CoA inhibitors

Nov. 15, 1996

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

ADIR claims new agents for treating bone resorption

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

Salagen Tablets more effective given during radiation therapy

Nov. 15, 1996

Patent coverage for Genta's BCL2-targeted antisense compounds

Nov. 15, 1996

Cell Therapeutics signs development and licensing agreements for lisofylline

Nov. 15, 1996

Auragen receives breast cancer research grant

Nov. 15, 1996

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...